Fermenta Biotech Ltd. has received approval from the Food Safety and Standards Authority of India (FSSAI) for its plant-based Vitamin D3 ingredient, VITADEE Green®, marking a significant milestone in the country’s nutrition and nutraceutical industry. The regulatory clearance allows the company to commercially market its plant-derived cholecalciferol for use in food fortification, dietary supplements, and other nutrition products, strengthening its position in the rapidly growing plant-based health and wellness segment.
Developed and manufactured entirely in India, VITADEE Green® is designed as a sustainable alternative to conventional Vitamin D3, which is commonly sourced from animal-derived lanolin. By offering a plant-based formulation, Fermenta aims to cater to the rising demand for vegan, vegetarian, and environmentally conscious nutritional products. The approval also aligns with the Government of India’s “Make in India” initiative by promoting indigenous manufacturing of high-value nutritional ingredients and reducing dependence on imports.
Vitamin D deficiency continues to be a major public health concern worldwide, including in India, despite abundant sunlight. The nutrient plays a critical role in maintaining bone health, supporting immune function, improving muscle strength, and regulating calcium absorption. Increasing consumer awareness about preventive healthcare and nutritional supplementation has led to growing demand for high-quality Vitamin D products across pharmaceutical, food, beverage, and dietary supplement industries. Fermenta’s latest innovation is expected to address this demand while offering manufacturers a clean-label, plant-based ingredient option.
The newly approved ingredient expands Fermenta Biotech’s already established portfolio of nutritional solutions. The company has long been recognized as one of the world’s leading manufacturers of Vitamin D3 and has supplied pharmaceutical and nutrition companies across global markets for several decades. With the addition of a plant-based alternative, Fermenta is strengthening its ability to serve evolving consumer preferences, particularly in markets where demand for vegan and sustainable products is increasing rapidly.
Industry trends indicate a significant shift toward plant-based ingredients driven by changing dietary preferences, sustainability goals, and greater focus on preventive healthcare. Food and supplement manufacturers are increasingly seeking ingredients that meet clean-label standards while maintaining quality, efficacy, and regulatory compliance. VITADEE Green® has been developed to deliver the same biological effectiveness as conventional Vitamin D3 while meeting the expectations of consumers looking for plant-based alternatives.
The FSSAI approval provides Fermenta with the opportunity to expand its presence in India’s fast-growing nutraceutical and functional food markets. The company can now supply the ingredient to manufacturers producing fortified foods, beverages, dietary supplements, and wellness products. The approval is also expected to strengthen domestic production capabilities and encourage greater innovation in India’s nutrition ecosystem by providing locally manufactured, globally competitive ingredients.
Beyond commercial opportunities, the approval reinforces Fermenta’s commitment to innovation, scientific research, and sustainable manufacturing. By investing in advanced nutritional ingredients developed within India, the company aims to contribute to improved public health outcomes while supporting environmentally responsible production practices. The launch of VITADEE Green® reflects the company’s broader strategy of expanding its portfolio with science-backed, high-quality ingredients that meet global standards and address emerging consumer needs.
